SI2710015T1 - Polimorf rifaximina in postopek za njegovo pripravo - Google Patents
Polimorf rifaximina in postopek za njegovo pripravoInfo
- Publication number
- SI2710015T1 SI2710015T1 SI201230663A SI201230663A SI2710015T1 SI 2710015 T1 SI2710015 T1 SI 2710015T1 SI 201230663 A SI201230663 A SI 201230663A SI 201230663 A SI201230663 A SI 201230663A SI 2710015 T1 SI2710015 T1 SI 2710015T1
- Authority
- SI
- Slovenia
- Prior art keywords
- rifaximin
- polymorph
- preparation
- Prior art date
Links
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title 1
- 229960003040 rifaximin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000890A ITMI20110890A1 (it) | 2011-05-19 | 2011-05-19 | Polimorfo di rifaximina e processo per la sua preparazione |
PCT/IB2012/052506 WO2012156951A1 (en) | 2011-05-19 | 2012-05-18 | Polymorph of rifaximin and process for the preparation thereof |
EP12731691.7A EP2710015B1 (en) | 2011-05-19 | 2012-05-18 | Polymorph of rifaximin and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2710015T1 true SI2710015T1 (sl) | 2016-09-30 |
Family
ID=44533008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201230663A SI2710015T1 (sl) | 2011-05-19 | 2012-05-18 | Polimorf rifaximina in postopek za njegovo pripravo |
Country Status (15)
Country | Link |
---|---|
US (1) | US8877770B2 (sl) |
EP (1) | EP2710015B1 (sl) |
KR (2) | KR20180032677A (sl) |
CN (1) | CN103619852B (sl) |
AU (1) | AU2012257360B2 (sl) |
BR (2) | BR112013029706A2 (sl) |
CA (1) | CA2844765C (sl) |
ES (1) | ES2586124T3 (sl) |
IT (1) | ITMI20110890A1 (sl) |
MX (1) | MX348393B (sl) |
PL (1) | PL2710015T3 (sl) |
PT (1) | PT2710015T (sl) |
RU (1) | RU2593750C2 (sl) |
SI (1) | SI2710015T1 (sl) |
WO (1) | WO2012156951A1 (sl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2522895T3 (es) | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
US9018684B2 (en) | 2009-11-23 | 2015-04-28 | California Institute Of Technology | Chemical sensing and/or measuring devices and methods |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
US20140308350A1 (en) | 2013-04-12 | 2014-10-16 | Alfa Wassermann S.P.A. | Nsaid administration and related compositions, methods and systems |
US9788466B2 (en) | 2013-04-16 | 2017-10-10 | Skyworks Solutions, Inc. | Apparatus and methods related to ground paths implemented with surface mount devices |
ITMI20131307A1 (it) | 2013-08-02 | 2015-02-02 | A M S A Anonima Materie Sint & Affini S P A | Processo per la preparazione di refaximina k |
ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
US9938298B2 (en) | 2014-05-12 | 2018-04-10 | Alfa Wassermann S.P.A. | Solvated crystal form of rifaximin, production, compositions and uses thereof |
CN106632396B (zh) * | 2017-01-06 | 2019-01-11 | 成都樵枫科技发展有限公司 | γ晶型利福昔明的制备方法和用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
ES2522895T3 (es) * | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
US8486956B2 (en) * | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
KR101674382B1 (ko) * | 2008-02-25 | 2016-11-09 | 샐릭스 파마슈티컬스 리미티드 | 리팍시민의 형태 및 이의 용도 |
-
2011
- 2011-05-19 IT IT000890A patent/ITMI20110890A1/it unknown
-
2012
- 2012-05-18 BR BR112013029706-9A patent/BR112013029706A2/pt active Search and Examination
- 2012-05-18 PL PL12731691T patent/PL2710015T3/pl unknown
- 2012-05-18 MX MX2013013465A patent/MX348393B/es active IP Right Grant
- 2012-05-18 EP EP12731691.7A patent/EP2710015B1/en active Active
- 2012-05-18 PT PT127316917T patent/PT2710015T/pt unknown
- 2012-05-18 US US14/118,740 patent/US8877770B2/en active Active
- 2012-05-18 ES ES12731691.7T patent/ES2586124T3/es active Active
- 2012-05-18 KR KR1020187007932A patent/KR20180032677A/ko not_active Application Discontinuation
- 2012-05-18 WO PCT/IB2012/052506 patent/WO2012156951A1/en active Application Filing
- 2012-05-18 BR BR112013029804A patent/BR112013029804A2/pt not_active IP Right Cessation
- 2012-05-18 CA CA2844765A patent/CA2844765C/en active Active
- 2012-05-18 AU AU2012257360A patent/AU2012257360B2/en active Active
- 2012-05-18 SI SI201230663A patent/SI2710015T1/sl unknown
- 2012-05-18 RU RU2013156344/04A patent/RU2593750C2/ru active
- 2012-05-18 KR KR1020137033427A patent/KR20140045413A/ko active Application Filing
- 2012-05-18 CN CN201280024381.6A patent/CN103619852B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CA2844765C (en) | 2019-07-16 |
CA2844765A1 (en) | 2012-11-22 |
CN103619852B (zh) | 2016-08-24 |
US8877770B2 (en) | 2014-11-04 |
EP2710015A1 (en) | 2014-03-26 |
AU2012257360B2 (en) | 2016-12-01 |
ES2586124T3 (es) | 2016-10-11 |
KR20180032677A (ko) | 2018-03-30 |
MX348393B (es) | 2017-06-08 |
CN103619852A (zh) | 2014-03-05 |
ITMI20110890A1 (it) | 2012-11-20 |
EP2710015B1 (en) | 2016-05-18 |
PL2710015T3 (pl) | 2017-08-31 |
KR20140045413A (ko) | 2014-04-16 |
RU2593750C2 (ru) | 2016-08-10 |
US20140107144A1 (en) | 2014-04-17 |
RU2013156344A (ru) | 2015-06-27 |
BR112013029706A2 (pt) | 2021-07-27 |
WO2012156951A1 (en) | 2012-11-22 |
BR112013029804A2 (pt) | 2016-09-06 |
PT2710015T (pt) | 2016-08-25 |
MX2013013465A (es) | 2014-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL246265B (en) | A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds | |
IL221299A (en) | A process for the preparation of Rifaximine pallimorphic configuration | |
ZA201206095B (en) | Process for the preparation of isoxazoline derivatives | |
ZA201305972B (en) | Method for the preparation of biphephos | |
PL2531286T3 (pl) | Sposób syntezy metanolu | |
PT2710015T (pt) | Polimorfo de rifaximina e processo para a sua preparação | |
HK1199649A1 (en) | Process for the preparation of polyamides | |
ZA201305582B (en) | Process for the preparation of 4-amino-5-fluoro-3-halo-6-(sunstituted)picolinates | |
ZA201204365B (en) | Darunavir polymorph and process for preparation thereof | |
SG11201400939YA (en) | Process for the preparation of methoxymelonal | |
GB2560284B (en) | Process for the 3-O-demethylation of morphinan compounds | |
HK1194733A1 (zh) | 製備 -酰基- -苯基磺酰基脯氨酰胺衍生物的方法及中間體 | |
ZA201403736B (en) | Process for the preparation of sterol derivatives | |
ZA201207397B (en) | Process for the preparation of dexlansoprazole | |
ZA201309713B (en) | Process for the preparation of paliperidone | |
EP2596007A4 (en) | PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS | |
ZA201300546B (en) | Process for the preparation of 3-haloalkylpyrazoles | |
GB201119690D0 (en) | Process for the preparation of compounds | |
SG11201400090UA (en) | Process for the preparation of olefins | |
PT2603319E (pt) | Processo para a preparação de uretanos | |
PL393916A1 (pl) | Sposób wytwarzania związków karbapenamowych | |
PT2390246T (pt) | Processo para a preparação de aminaftona | |
PL2702045T3 (pl) | Nowy sposób sporządzania Etrawiryny | |
ZA201309732B (en) | Process for the preparation of dexlansoprazole | |
PT2598504E (pt) | Novo processo de fabrico de dimiracetam |